Collective Scientific, LLC is a leading provider of in silico drug design services, utilizing cutting-edge technologies such as cloud computing, machine learning, and artificial intelligence. Our goal is to revolutionize the field of pharmaceutical research by turning drug discovery into an engineering problem. Unlike traditional methods that rely on scanning libraries of known chemicals, our software models de novo therapies based on three-dimensional crystal structures.

This allows us to screen, refine, and optimize drug candidates in a single step, replacing time-consuming high throughput screening and structure-based drug discovery approaches. We understand the challenges faced by small labs and rare disease research, where resources are often limited. That's why we have developed a software suite that significantly shortens the drug discovery timeline, empowering laboratories of all sizes to increase productivity and explore a wider array of diseases.

With our automated machine learning and proprietary algorithms, we provide a comprehensive report with ranked, optimized compounds ready for in vivo studies in under two weeks. Our cohesive software suite, which includes energy minimization tools and machine learning heuristics, replaces numerous cumbersome and antiquated systems. Backed by a scalable distributed cloud infrastructure, we deliver high-quality results rapidly and at a significantly higher return on investment.

If you're ready to accelerate your drug discovery research, start your free project review with Collective Scientific today